[37] Medical uses [edit] European Union [edit] In the European Union, semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes as an adjunct to diet and exercise as monotherapy when metformin is considered inappropriate due to intolerance or contraindications, [16] [17] in addition to other medicinal products for the treatment of diabetes
However, the way semaglutide interacts with the thyroidand the medication you might take for itrequires careful attention
Safety Considerations, Side Effects, and Legal Status When using Melanotan peptides, we need to pay close attention to safety, possible side effects, and the laws around these products
Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D
Access disparities exist, with studies suggesting lower utilization rates among Black, Hispanic, and other minority populations despite higher rates of diabetes and obesity in these communities